Nomura Holdings Inc. cut its stake in shares of The Clorox Company (NYSE:CLX – Free Report) by 68.4% during the fourth quarter, according to its most recent disclosure with the SEC. The institutional investor owned 2,516 shares of the company’s stock after selling 5,455 shares during the period. Nomura Holdings Inc.’s holdings in Clorox were worth $359,000 at the end of the most recent reporting period.
Other large investors have also recently added to or reduced their stakes in the company. Fortitude Family Office LLC acquired a new position in shares of Clorox in the fourth quarter worth $29,000. Northwest Financial Advisors acquired a new stake in shares of Clorox in the fourth quarter valued at about $29,000. Core Wealth Advisors Inc. bought a new stake in Clorox during the 4th quarter valued at approximately $29,000. First United Bank & Trust bought a new position in Clorox in the 4th quarter worth approximately $31,000. Finally, Tyler Stone Wealth Management lifted its holdings in shares of Clorox by 64.5% during the third quarter. Tyler Stone Wealth Management now owns 255 shares of the company’s stock worth $33,000 after buying an additional 100 shares during the last quarter. Institutional investors and hedge funds own 78.53% of the company’s stock.
Clorox Stock Performance
NYSE CLX opened at $136.64 on Friday. The Clorox Company has a 1-year low of $114.68 and a 1-year high of $169.14. The company has a 50 day moving average of $137.62 and a 200-day moving average of $144.02. The company has a current ratio of 0.90, a quick ratio of 0.53 and a debt-to-equity ratio of 9.73. The firm has a market cap of $16.97 billion, a price-to-earnings ratio of 70.80, a PEG ratio of 2.18 and a beta of 0.39.
Analyst Ratings Changes
CLX has been the topic of a number of research reports. Citigroup dropped their target price on shares of Clorox from $155.00 to $150.00 and set a “neutral” rating on the stock in a research report on Wednesday, May 1st. The Goldman Sachs Group assumed coverage on shares of Clorox in a research note on Friday, March 1st. They issued a “sell” rating and a $140.00 target price for the company. JPMorgan Chase & Co. cut their price target on Clorox from $159.00 to $158.00 and set a “neutral” rating for the company in a report on Wednesday, May 1st. Wells Fargo & Company decreased their price objective on Clorox from $140.00 to $135.00 and set an “underweight” rating on the stock in a report on Thursday, May 2nd. Finally, DA Davidson restated a “neutral” rating and issued a $162.00 target price on shares of Clorox in a research note on Wednesday, April 17th. Four equities research analysts have rated the stock with a sell rating and fourteen have assigned a hold rating to the stock. According to data from MarketBeat, Clorox has a consensus rating of “Hold” and an average price target of $146.43.
Read Our Latest Stock Analysis on CLX
Clorox Company Profile
The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.
Featured Articles
- Five stocks we like better than Clorox
- Why Understanding Call Option Volume is Essential to Successful Options Trading
- McDonald’s Stock: Balancing Value and Innovation
- Canada Bond Market Holiday: How to Invest and Trade
- MarketBeat Week in Review – 6/17 – 6/21
- What Are Dividend Contenders? Investing in Dividend Contenders
- Sarepta Therapeutics Stock Soars on FDA Approval
Want to see what other hedge funds are holding CLX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Clorox Company (NYSE:CLX – Free Report).
Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.